CompletedNCT00541346
Methylphenidate patches for children with autism and ADHD symptoms
About this title
Read the official source — NCT00541346Researchers studied Methylphenidate Transdermal System to find out how it affected ADHD symptoms in people with ADHD.
Medication studyAges 6–11United States
Understand this study
What did researchers investigate?
Researchers studied Methylphenidate Transdermal System to find out how it affected ADHD symptoms in people with ADHD.
Who was this study for?
Listed age limits: 6 years to 11 years.
- Listed locations
- Oklahoma CitySee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateSeptember 2007
- Recruitment status
- Completed
- Enrollment listed in the registry
- 16
- Sponsor
- University of Oklahoma
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States
- Age range
- From 6 Years to 11 Years
- Official registry ID
- NCT00541346
- Official title
Show the full official title
Phase III Study of Autism Co-Morbid for Attention Deficit Hyperactivity Disorder
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Oklahoma City
Interested in joining this study?
Questions about this study
What did researchers investigate?
Researchers studied Methylphenidate Transdermal System to find out how it affected ADHD symptoms in people with ADHD.
Who is behind this study?
The study sponsor is University of Oklahoma, a university.
Did this study involve medication?
Yes. The study involved medication, including Methylphenidate Transdermal System.
Who was this study for?
Listed age limits: 6 years to 11 years.
